
Opinion|Videos|January 7, 2025
When to Consider Systemic Treatment for Prurigo Nodularis Patients
Author(s)TJ Chao, MPAS, PA-C
TJ Chao, MPAS, PA-C, discusses how systemic treatments for prurigo nodularis are considered for patients with moderate to severe disease, highlighting key patient-specific factors such as comorbidities and disease severity when initiating treatment.
Advertisement
Episodes in this series

Video content above is prompted by the following:
For which type of patient would you consider systemic treatments for prurigo nodularis patients?
What patient-specific factors do you consider when starting treatment?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis
2
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
3
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
4
Social Media Mythbusters: The Summer Skin Care "Shutdown"
5












